Latest News
News
CDC says about 20% get long COVID. New models try to define it
“Those numbers are high and it’s alarming. But we’ve been sounding the alarm for quite some time, and we’ve been assuming that about one in five...
News
Hospital medicine gains popularity among newly minted physicians
At the same time, the percentage of general internists in a mixed practice setting decreased from 52% to 23%.
News
ADA prioritizes heart failure in patients with diabetes
Patients with diabetes should have annual screening for biomarkers of early-stage heart failure, and treatment should prioritize an SGLT2...
Conference Coverage
LDL lowering to specific targets may offset risk from high Lp(a)
Researchers have developed a novel app to show how the increased risk of coronary events due to elevated lipoprotein(a) levels can be countered by...
News
Children & COVID: Rise in new cases slows
One measure of overall prevalence declined for the first time since the beginning of the pandemic.
News
FDA withdraws lymphoma drug approval after investigation
Last February, the FDA said it was investigating a possible increased risk of death associated with umbralisib. Five months later, the results are...
FDA/CDC
FDA clears Abbott Freestyle Libre 3 glucose sensor
New features on the Freestyle Libre 3 system include real-time readings, improved accuracy, and smaller size.
News
Can lung cancer ID be as easy as breathing into an analyzer?
Breathomics testing is considered a promising lung cancer screening tool.
News
Hearing, vision loss combo a colossal risk for cognitive decline
Those with dual sensory impairment had an eightfold higher risk for cognitive impairment.
News
Immunotherapy now first line for esophageal cancer
The “approvals bring two first-line immunotherapy-based treatment options at once ... to newly diagnosed patients with unresectable advanced or...